A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen
Clinical trial NCT05138159 · UNKNOWN
Trial details
- NCT number
- NCT05138159
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-05-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.